ENTECAVIR 0.5 MG TABLET

ENTECAVIR ANHYDROUS
$0.2110per EA

Strength

.5 mg/1

NDC

42494045730

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ENTECAVIR ANHYDROUS

Approval Type

Generic (ANDA)

FDA Application

ANDA216857

On Market Since

5/15/2025

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Analog
Nucleoside Reverse Transcriptase Inhibitors

Price History

1W

0.0%

1M

-4.9%

3M

-6.9%

6M

-12.7%

1Y

N/A

3Y

N/A

5Y

N/A

All

-19.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.